{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:55:30Z","timestamp":1789844130031,"version":"4.0.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.prp.2024.155669","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T16:29:59Z","timestamp":1729528199000},"page":"155669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Leukemic B cells expression of CD200 and Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1, CD305) in Chronic Lymphocytic Leukemia patients in relation to Treg frequency"],"prefix":"10.1016","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8967-9106","authenticated-orcid":false,"given":"Reham","family":"Hammad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Z.","family":"Kandeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Sack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Kujumdshiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwa","family":"Kamhawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omaima I.","family":"Abo-Elkheir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma EL-Zahraa","family":"Abd El Hakam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alya","family":"Mashaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Aziz A.","family":"Zidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2105-107X","authenticated-orcid":false,"given":"Nadia M.","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2024.155669_bib1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/17474086.2023.2243385","article-title":"Trends of chronic lymphocytic leukemia incidence and mortality in the United States: a population-based study over the last four decades","volume":"16","author":"Alabrach","year":"2023","journal-title":"Expert. Rev. Hematol."},{"key":"10.1016\/j.prp.2024.155669_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-022-01516-w","article-title":"BCL-2 expression promotes immunosuppression in chronic lymphocytic leukemia by enhancing regulatory T cell differentiation and cytotoxic T cell exhaustion","volume":"21","author":"Liu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2024.155669_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/leu.2017.177","article-title":"Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups","volume":"32","author":"Burns","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.prp.2024.155669_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.594556","article-title":"Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia","volume":"11","author":"Griggio","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2024.155669_bib5","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.3390\/ijms22136665","article-title":"NK cells in chronic lymphocytic leukemia and their therapeutic implications","volume":"22","author":"Sportoletti","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2024.155669_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154960","article-title":"Hsa-miR-21\u20135p reflects synovitis and tenosynovitis components of musculoskeletal ultrasonography Seven-joint scores in rheumatoid arthritis disease and predicts the disease flare","volume":"253","author":"Hammad","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2024.155669_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/JAA.S398494","article-title":"MicroRNA-146a-5p and microRNA-210-3p Correlate with T Regulatory Cells Frequency and Predict Asthma Severity in Egyptian Pediatric Population","volume":"16","author":"Eldosoky","year":"2023","journal-title":"J. Asthma Allergy"},{"key":"10.1016\/j.prp.2024.155669_bib8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2020.07.022","article-title":"FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets","volume":"490","author":"Saleh","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2024.155669_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1156212","article-title":"Targeting immune checkpoints in anti-neutrophil cytoplasmic antibodies associated vasculitis: the potential therapeutic targets in the future","volume":"14","author":"Pan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2024.155669_bib10","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2308214120","article-title":"Dysregulated CD200-CD200R signaling in early diabetes modulates microglia-mediated retinopathy","volume":"120","author":"Pfeifer","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2024.155669_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/hon.2206","article-title":"A.E.-H. oncology, undefined 2017, Upregulation of CD200 is associated with regulatory T cell expansion and disease progression in multiple myeloma","volume":"35","author":"Aref","year":"2015","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.prp.2024.155669_bib12","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.3390\/biomedicines11123326","article-title":"CD200\/CD200R: Bidirectional Role in Cancer Progression and Immunotherapy","volume":"11","author":"Nip","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.prp.2024.155669_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-3-030-35582-1_8","article-title":"CD200-CD200R Pathway in the Regulation of Tumor Immune Microenvironment and Immunotherapy","volume":"1223","author":"Liu","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.prp.2024.155669_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01793","article-title":"Leukocyte Associated Immunoglobulin Like Receptor 1 Regulation and Function on Monocytes and Dendritic Cells During Inflammation","volume":"11","author":"Carvalheiro","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2024.155669_bib15","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/1753425920942570","article-title":"Immunoregulatory complement receptor-1 and leukocyte-associated Ig-like receptor-1 expression on leukocytes in Psoriasis vulgaris","volume":"26","author":"Hammad","year":"2020","journal-title":"Innate Immun."},{"key":"10.1016\/j.prp.2024.155669_bib16","doi-asserted-by":"crossref","unstructured":"R. Hammad, R. Aglan, S.A. Mohammed, E.A.-e. Awad, M.A. Elsaid, H.M. Bedair, S.K. Khirala, M.A. Selim, A.A. Abo Elqasem, A. Rushdi, M. Ali, O.I. Abo-Elkheir, E.F. Sanad, N.M. Hamdy. Cytotoxic T cell expression of leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) in viral hepatitis C-mediated hepatocellular carcinoma. Int. J. Mol. Sci. 23, 12541. https:\/\/doi.org\/10.3390\/ijms232012541.","DOI":"10.3390\/ijms232012541"},{"key":"10.1016\/j.prp.2024.155669_bib17","doi-asserted-by":"crossref","first-page":"16136","DOI":"10.3390\/ijms232416136","article-title":"LAIR-1, an ITIM-Containing Receptor Involved in Immune Disorders and in Hematological Neoplasms.","volume":"23","author":"Van Laethem","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2024.155669_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10585-019-09966-1","article-title":"The extracellular matrix in tumor progression and metastasis","volume":"36","author":"Eble","year":"2019","journal-title":"Clin. Exp. Metastas-.-."},{"key":"10.1016\/j.prp.2024.155669_bib19","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.hoc.2004.04.001","article-title":"Clinical staging and prognostic markers in chronic lymphocytic leukemia","volume":"18","author":"Rai","year":"2004","journal-title":"Hematol. Oncol. Clin. North. Am."},{"key":"10.1016\/j.prp.2024.155669_bib20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/ajcp\/108.4.378","article-title":"Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b)","volume":"108","author":"Moreau","year":"1997","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2024.155669_bib21","first-page":"1640","article-title":"undefined 1994, The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL","volume":"8","author":"Matutes","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.prp.2024.155669_bib22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2249.2011.04466.x","article-title":"Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+","volume":"166","author":"Piper","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.prp.2024.155669_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkac1001","article-title":"HUSCH: an integrated single-cell transcriptome atlas for human tissue gene expression visualization and analyses","volume":"51","author":"Shi","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.prp.2024.155669_bib24","first-page":"gkab909","article-title":"SignaLink3: a multi-layered resource to uncover tissue-specific signaling networks","volume":"50","author":"Csabai","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.prp.2024.155669_bib25","unstructured":"J.C. Oliveros, Venny. An interactive tool for comparing lists with Venn\u2019s diagrams. 2007\u20132015, \u3008https:\/\/bioinfogp.cnb.csic.es\/tools\/venny\/index.html\u3009."},{"key":"10.1016\/j.prp.2024.155669_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000533234","article-title":"Immune Dysfunction and Infection - Interaction between CLL and Treatment: A Reflection on Current Treatment Paradigms and Unmet Needs","volume":"147","author":"Gargiulo","year":"2024","journal-title":"Acta Haematol."},{"key":"10.1016\/j.prp.2024.155669_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1297116","article-title":"p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation","volume":"12","author":"Lopresti","year":"2024","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.prp.2024.155669_bib28","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.3109\/10428194.2010.503820","article-title":"Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemia","volume":"51","author":"Gonzalez-Rodriguez","year":"2010","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.prp.2024.155669_bib29","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.3109\/10428194.2012.656634","article-title":"Reciprocal changes in regulatory T cells and Th17 helper cells induced by exercise in patients with chronic lymphocytic leukemia","volume":"53","author":"Perry","year":"2012","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.prp.2024.155669_bib30","first-page":"52","article-title":"V.D., Regulatory T-cells in chronic lymphocytic leukemia: actor or innocent bystander?","volume":"3","author":"D\u2019Arena","year":"2013","journal-title":"Am. J. Blood Res."},{"key":"10.1016\/j.prp.2024.155669_bib31","article-title":"Activated Galectin-9\/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia","volume":"35","author":"Pang","year":"2021"},{"key":"10.1016\/j.prp.2024.155669_bib32","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/s41417-023-00602-5","article-title":"Immuno-regulatory malignant B cells contribute to Chronic Lymphocytic Leukemia progression","volume":"30","author":"M\u00e9kinian","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.prp.2024.155669_bib33","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1182\/blood.V126.23.2928.2928","article-title":"Quantitative and Qualitative Analysis of Regulatory T Cells (Tregs) in B Cell Chronic Lymphocytic Leukemia (B-CLL)","volume":"126","author":"Mpakou","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.prp.2024.155669_bib34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1182\/blood-2016-12-756585","article-title":"CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies","volume":"130","author":"Al Sayed","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.prp.2024.155669_bib35","first-page":"677","article-title":"J. Chen, Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia","volume":"20","author":"Giannopoulos","year":"2008","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2024.155669_bib36","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1182\/bloodadvances.2017006809","article-title":"Emerging role of BCR signaling inhibitors in immunomodulation of chronic lymphocytic leukemia","volume":"21","author":"Maharaj","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.prp.2024.155669_bib37","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.3109\/10428194.2014.986479","article-title":"Regulatory T-cell and T-helper 17 balance in chronic lymphocytic leukemia progression and autoimmune cytopenias","volume":"56","author":"Lad","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.prp.2024.155669_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.584427","article-title":"CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance","volume":"10","author":"D\u2019Arena","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2024.155669_bib39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2567.2001.01163.x","article-title":"The unusual distribution of the neuronal\/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans","volume":"102","author":"Wright","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.prp.2024.155669_bib40","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.4049\/jimmunol.0900252","article-title":"Lack of CD200 enhances pathological T cell responses during influenza infection","volume":"183","author":"Rygiel","year":"2009","journal-title":"J. Immun."},{"key":"10.1016\/j.prp.2024.155669_bib41","first-page":"111","article-title":"Study of CD200 in chronic lymphocytic leukemia","volume":"37","author":"Baraka","year":"2012","journal-title":"Egy. Hemat. J."},{"key":"10.1016\/j.prp.2024.155669_bib42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4049\/jimmunol.182.Supp.88.15","article-title":"Potential role for serum soluble CD200 in human Chronic Lymphocytic Leukemia (88.15)","volume":"182","author":"Wong","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.prp.2024.155669_bib43","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3324\/haematol.2013.096362","article-title":"Clinical significance of LAIR-1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia","volume":"99","author":"Perbellini","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.prp.2024.155669_bib44","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/leu.2008.21","article-title":"Lack of the leukocyte-associated Ig-like receptor-1 expression in high-risk chronic lymphocytic leukaemia results in the absence of a negative signal regulating kinase","volume":"22","author":"Poggi","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.prp.2024.155669_bib45","first-page":"42","article-title":"Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing","volume":"78","author":"Rawstron","year":"2010","journal-title":"Cytom. Part B: Clin. Cytom."},{"issue":"2","key":"10.1016\/j.prp.2024.155669_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031903","article-title":"Defective expression and function of the leukocyte associated Ig-like receptor 1 in B lymphocytes from systemic lupus erythematosus patients","volume":"7","author":"Colombo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2024.155669_bib47","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s13277-013-0832-x","article-title":"Regulatory T cells in chronic lymphocytic leukemia: Implication for immunotherapeutic interventions","volume":"34","author":"Jadidi-Niaragh","year":"2013","journal-title":"Tumor Biol."},{"key":"10.1016\/j.prp.2024.155669_bib48","doi-asserted-by":"crossref","first-page":"13551","DOI":"10.18632\/oncotarget.6948","article-title":"Low expression of CD200 predicts shorter time-to-treatment in chronic lymphocytic leukemia","volume":"7","author":"Miao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2024.155669_bib49","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1158\/2326-6066.CIR-16-0329","article-title":"Soluble PD-L1 as a biomarker in malignant melanoma treated with checkpoint blockade","volume":"5","author":"Zhou","year":"2017","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.prp.2024.155669_bib50","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.leukres.2008.08.021","article-title":"Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockade","volume":"33","author":"Pallasch","year":"2008","journal-title":"Leuk. Res."},{"key":"10.1016\/j.prp.2024.155669_bib51","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4049\/jimmunol.1701753","article-title":"Leukocyte-associated Ig-like receptor 1 inhibits Th1 responses but is required for natural and induced monocyte-dependent Th17 responses","volume":"201","author":"Agashe","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.prp.2024.155669_bib52","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1084\/jem.20052554","article-title":"Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1","volume":"203","author":"Lebbink","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.prp.2024.155669_bib53","doi-asserted-by":"crossref","first-page":"96","DOI":"10.18632\/oncotarget.28354","article-title":"The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy","volume":"14","author":"Shao","year":"2023","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2024.155669_bib54","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/eji.200636678","article-title":"Regulated expression of the inhibitory receptor LAIR-1 on human peripheral T cells during T cell activation and differentiation","volume":"37","author":"Jansen","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.prp.2024.155669_bib55","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1002\/1521-4141(200112)31:12<3667::AID-IMMU3667>3.0.CO;2-G","article-title":"Leukocyte-associated Ig-like receptor-1 prevents granulocyte-monocyte colony stimulating factor-dependent proliferation and Akt1\/PKB alpha activation in primary acute myeloid leukemia cells","volume":"31","author":"Zocchi","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.prp.2024.155669_bib56","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ncb3158","article-title":"The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia development","volume":"17","author":"Kang","year":"2015","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.prp.2024.155669_bib57","first-page":"1","article-title":"Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200","volume":"7","author":"Mahadevan","year":"2019","journal-title":"J. Immuno. Ther. Canc."},{"key":"10.1016\/j.prp.2024.155669_bib58","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169519","article-title":"LAIR-1 agonism as a therapy for acute myeloid leukemia","volume":"133","author":"Lovewell","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prp.2024.155669_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.996026","article-title":"Blocking LAIR-1 signaling in immune cells inhibits tumor development","volume":"13","author":"Xie","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2024.155669_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121997","article-title":"Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer","volume":"330","author":"Elanany","year":"2023","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.prp.2024.155669_bib61","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jdiacomp.2007.10.006","article-title":"Influence of vitamin E supplementation on endothelial complications in type 2 diabetes mellitus patients who underwent coronary artery bypass graft","volume":"23","author":"Hamdy","year":"2009","journal-title":"J. Diabetes Complicat."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824005806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824005806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T03:55:36Z","timestamp":1732334136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033824005806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":61,"alternative-id":["S0344033824005806"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155669","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leukemic B cells expression of CD200 and Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1, CD305) in Chronic Lymphocytic Leukemia patients in relation to Treg frequency","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155669"}}